This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4,563,818,934 bupropion HCl XL 150 mg tablets in 500-count packages, with a potential value of $4,057.34. The contract does not have a set-aside designation and has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary vehicle for the company to provide a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 5/31/24, 10:14 AM